CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 50 filers reported holding CYTOSORBENTS CORP in Q1 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1 | 0.0% | 1 | 0.0% | 0.00% | – |
Q1 2024 | $1 | 0.0% | 1 | 0.0% | 0.00% | – |
Q4 2023 | $1 | -50.0% | 1 | 0.0% | 0.00% | – |
Q3 2023 | $2 | -100.0% | 1 | -100.0% | 0.00% | – |
Q3 2022 | $43,000 | -44.2% | 31,434 | -10.9% | 0.00% | -100.0% |
Q2 2022 | $77,000 | -33.0% | 35,293 | +203.4% | 0.00% | -50.0% |
Q2 2020 | $115,000 | – | 11,634 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Skylands Capital, LLC | 1,126,300 | $8,706,000 | 1.93% |
Sargent Investment Group, LLC | 471,755 | $3,647,000 | 1.68% |
Manatuck Hill Partners, LLC | 125,000 | $966,000 | 0.89% |
Soleus Capital Management, L.P. | 69,600 | $538,000 | 0.63% |
EAM Investors, LLC | 136,098 | $1,052,000 | 0.33% |
Granahan Investment Management | 691,130 | $5,342,000 | 0.29% |
EAM Global Investors LLC | 61,795 | $478,000 | 0.28% |
Winning Points Advisors, LLC | 35,000 | $269,000 | 0.26% |
Leap Investments LP | 14,200 | $110,000 | 0.16% |
Avenir Corp | 150,600 | $1,164,000 | 0.16% |